
Opinions
Jim Cramer - Mad Money
Catalent
CTLT-N
DON'T BUY
Mar 22, 2023
N/A
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
Danaher (he owns) or Illumina could buy CTLT, at least that's the talk. Until something happens, he won't buy this.